KI-Beratung Beta

Produktbild: Fundamentals of Pharmacology for Paramedics

Fundamentals of Pharmacology for Paramedics

Aus der Reihe Fundamentals

57,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

17.03.2022

Herausgeber

Ian Peate + weitere

Verlag

John Wiley & Sons

Seitenzahl

368

Maße (L/B/H)

17,9/25,5/2,3 cm

Gewicht

784 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-1-119-72428-5

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

17.03.2022

Herausgeber

Verlag

John Wiley & Sons

Seitenzahl

368

Maße (L/B/H)

17,9/25,5/2,3 cm

Gewicht

784 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-1-119-72428-5

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Ein neues Kapitel für Ihre Bücher

Ein neues Kapitel für Ihre Bücher

Schenken Sie Ihren alten Schätzen ein zweites Leben und erhalten Sie dafür eine Thalia Geschenkkarte.

Jetzt verkaufen
Jetzt verkaufen

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Fundamentals of Pharmacology for Paramedics
  • Contributors xiii

    Preface xxi

    Acknowledgements xxiii

    Prefixes, suffixes and abbreviations xxiv

    Chapter 1: Introduction to pharmacology 1

    Suzanne Evans and Tanya Somani

    Aim 1

    Naming and classifying drugs 5

    How drugs bring about their actions 6

    How are we able to manipulate physiological function using drugs? 6

    Receptors as sites of drug action 7

    Enzymes as sites of drug action 7

    Ion channels 7

    Transport molecules 9

    Selectivity of binding and its effect 11

    The drug-body interaction is a dynamic process 11

    Conclusion 14

    Glossary 14

    References 15

    Further reading 15

    Multiple-choice questions 15

    Chapter 2: How to use pharmaceutical and prescribing reference guides 18

    Nigel Conway and Jennifer Dod

    Aim 18

    Introduction 19

    HCPC Standards of conduct, performance and ethics 19

    HCPC Standards of proficiency for paramedics 20

    Joint Royal Colleges Ambulance Liaison Committee (JRCALC) Clinical Practice Guidelines 21

    JRCALC Update information 22

    How to navigate the JRCALC Guidelines 23

    JRCALC Pocket Book 30

    JRCALC Guidelines digital application (app) 31

    Useful additional resources 32

    British National Formulary (BNF) 32

    Monthly Index of Medical Specialities 33

    Electronic Medicines Compendium (EMC) 34

    Conclusion 34

    Disclaimer 35

    References 35

    Further reading 35

    Multiple-choice questions 35

    Chapter 3: Legal and ethical issues 37

    Claire Leader, Emma Senior, Deborah Flynn and Paul Younger

    Aim 37

    Introduction 38

    The law 38

    Ethical principles and theories 39

    Regulatory bodies 43

    Research 45

    Conclusion 47

    Glossary 47

    References 48

    Further reading 49

    Multiple-choice questions 50

    Chapter 4: Medicines management and the role of the paramedic 52

    Annette Hand, Carol Wills and Paul Younger

    Aim 52

    Introduction 53

    Medicines management 53

    Manufacturing, marketing, procurement and sale 54

    Selection 55

    Supply 55

    Patient-specific directions 56

    Prescriptions 56

    Patient Group Directions 56

    Exemptions 57

    Prescribing 59

    Handling and administration 60

    Special consideration: Controlled Drugs and critical medications 62

    Groups requiring special considerations 63

    Monitoring for side-effects 64

    Medicines optimisation 64

    Safety in medicines management 65

    Storage and disposal 66

    Conclusion 66

    References 66

    Further reading 68

    Multiple-choice questions 68

    Chapter 5: Pharmacodynamics and pharmacokinetics 70

    Dan Davern

    Aim 70

    Introduction 70

    Professional regulatory council 71

    Programmes of education and training 71

    Pharmacokinetics 71

    The pharmacokinetic processes 71

    Phase 1: absorption 72

    Phase 2: distribution 76

    Phase 3: metabolism (biotransformation) 77

    Phase 4: elimination 79

    Pharmacodynamics 81

    Agonists and antagonists 82

    Drug potency and efficacy 84

    Therapeutic index 84

    Adverse drug reactions 85

    Conclusion 87

    References 87

    Further reading 87

    Multiple-choice questions 88

    Chapter 6: Drug formulations 90

    Sarah Dineen-Griffin and Barbara C. Wimmer

    Aim 90

    Introduction 91

    Routes of drug administration 91

    Parenteral administration 92

    Intravenous administration 92

    Subcutaneous administration 93

    Intramuscular administration 93

    Intraosseous administration 95

    Intrathecal administration 95

    Intradermal administration 95

    Formulations 97

    Localised versus long-acting injectable formulations 97

    Topical formulations 97

    Inhaled formulations 99

    Enteral formulations 101

    Rectal formulations 105

    Conclusion 105

    Glossary 106

    References 106

    Further reading 108

    Multiple-choice questions 108

    Chapter 7: Adverse drug reactions 110

    Matt Dixon

    Aim 110

    What is an adverse drug reaction? 110

    Classification of adverse drug reactions 111

    How prevalent are adverse drug reactions? 111

    Who is more likely to experience adverse drug reactions? 112

    Recognising signs and symptoms of adverse drug reactions 114

    Anaphylaxis 114

    Rashes and skin eruptions 115

    Serum sickness 115

    Renal disorders 115

    Geriatric syndrome 116

    Idiosyncratic reactions 117

    Preventing adverse drug reactions 117

    Managing adverse drug reactions 117

    Reporting adverse drug reactions 119

    Conclusion 122

    References 122

    Further reading 123

    Multiple-choice questions 123

    Chapter 8: Analgesics 125

    Tom Mallinson

    Aim 125

    Pain and analgesia 125

    Understanding and assessing pain 125

    Why do we treat pain? 126

    Psychology of pain 126

    Physiology of pain 127

    Pain transmission 127

    Pain modulation 128

    Types of pain 129

    Assessment of pain 131

    Approach to analgesia 132

    Paracetamol 133

    Non-steroidal anti-inflammatory drugs 133

    Inhalational analgesia 136

    Opioids 137

    Antagonists 141

    Atypical analgesics 142

    Antidepressants and antiepileptics 143

    Adjuncts to analgesia 143

    Magnesium sulfate 143

    Local anaesthetics 143

    Conclusion 144

    Glossary 145

    References 146

    Further reading 147

    Multiple-choice questions 147

    Chapter 9: Antibacterials 149

    Dean Whiting, Deborah Flynn and Dawn Ball

    Aim 149

    Introduction 149

    Language and terminology 150

    Antibacterial mechanisms of action 150

    Disruption of bacterial cell wall synthesis: beta-lactams 151

    Interference in folate metabolism: sulfonamides, trimethoprim 151

    Inhibition of bacterial DNA synthesis: quinolones 151

    Inhibition of bacterial protein synthesis: tetracyclines, aminoglycosides, macrolides, chloramphenicol, lincosamides 151

    Choosing the right treatment 151

    Antimicrobial resistance 151

    Preventing antimicrobial resistance 152

    Antimicrobial stewardship (AMS) 153

    Antibacterials by clinical use 153

    Beta-lactams 153

    Tetracyclines 157

    Chloramphenicol 158

    When administered in combination with phenytoin, monitor seizure pattern. Aminoglycosides 159

    Macrolides 161

    Lincosamides 162

    Conclusion 163

    References 163

    Further reading 164

    Multiple-choice questions 164

    Chapter 10: Medications used in the cardiovascular system 167

    Lisa Clegg and Fraser Russell

    Aim 167

    Cardiovascular diseases 167

    Hypertension and heart failure 168

    Management of hypertension and heart failure 168

    Acute coronary Syndrome (ACS) 173

    Management of acute coronary syndrome 173

    Conclusion 177

    Glossary 177

    References 178

    Further reading 179

    Multiple-choice questions 180

    Chapter 11: Medications used in the renal system 182

    Anthony Kitchener

    Aim 182

    Introduction 183

    Acute kidney injury 183

    Chronic kidney disease 185

    Management of CKD 185

    Electrolyte abnormalities resulting from poor renal function 187

    Hyponatraemia (low serum sodium) 187

    Hypokalaemia (low serum potassium) and hyperkalaemia (high serum potassium) 187

    Urinary retention and incontinence 187

    Drug-induced renal damage 188

    Drugs that act on the renal system 188

    Diuretics 188

    Drugs used to treat urinary retention and urinary incontinence 193

    Conclusion 195

    Glossary 198

    References 200

    Further reading 201

    Multiple-choice questions 201

    Chapter 12: Medications and diabetes mellitus 203

    Hayley Croft and Olivia Thornton

    Aim 203

    Introduction 204

    Hormonal control of blood glucose 204

    Monitoring diabetes 205

    Measuring blood glucose 206

    Measuring ketones 207

    Drug use in diabetes 207

    Insulin replacement therapy 207

    Metformin 209

    Sulfonylureas 209

    Incretin mimetics 210

    SGLT-2 inhibitors 210

    Thiazolidinediones 211

    Alpha-glucosidase inhibitors 211

    Drug use in diabetic emergencies 211

    Hypoglycaemic emergency 211

    Hyperglycaemic emergency 216

    Management of hyperglycaemia 218

    Conclusion 219

    Glossary 219

    References 220

    Multiple-choice questions 221

    Chapter 13: Medications used in the respiratory system 224

    Jason McKenna

    Aim 224

    Introduction 225

    Anatomy and physiology 225

    Nervous system control 226

    Common respiratory emergencies 227

    Asthma 227

    Chronic obstructive pulmonary disease 230

    Croup 231

    Pneumonia 232

    Pneumothorax 232

    Pulmonary oedema 233

    Classes of medications 234

    Bronchodilators 234

    Diuretics 236

    Nitrates 236

    Steroids 237

    Medical gases 238

    Oxygen devices 238

    Conclusion 239

    Find out more 239

    References 239

    Further reading 241

    Multiple-choice questions 241

    Chapter 14: Medications used in the gastrointestinal system 243

    George Bell-Starr and Ashley Ingram

    Aim 243

    Introduction 244

    Anatomy and physiology of the gastrointestinal system 244

    Nausea and vomiting 244

    H1 receptor antagonists (antihistamines) 246

    Dopamine (D2) receptor antagonists 246

    Serotonin (5-HT3) receptor antagonists 246

    Peptic ulcers 247

    Helicobacter pylori infections 247

    Non-steroidal anti-inflammatory drugs 248

    Symptoms of peptic ulcer 248

    Constipation 249

    Laxatives 249

    Gastro-oesophageal reflux disease 251

    Drug interventions (patients with confirmed endoscope diagnosis) 252

    Paramedic practice 252

    Antidiarrhoeals 254

    Inflammatory bowel disease (IBD) 255

    Crohn's disease 255

    Ulcerative colitis 255

    Drug treatment for inflammatory bowel disease 255

    Conclusion 257

    References 257

    Multiple-choice questions 258

    Chapter 15: Medication and the nervous system 261

    Geoffrey Bench, Alastair Dolan, Lena Solanki, Paul Doherty, Charlotte White, Ricky Lawrence and Emma Beadle

    Aim 261

    Introduction 261

    The nervous system 262

    Parkinson disease and parkinsonism 262

    Infections 264

    Dementia 264

    Drugs used in dementia 265

    Cautions 266

    Epilepsy 267

    Antiepileptic medication 268

    Psychogenic non-epileptic seizures (PNES) versus bilateral tonic clonic seizures (BTCS) 268

    Emergency medication in the prehospital setting 268

    Strokes (including transient ischaemic attacks) 270

    Definition of a stroke and a transient ischaemic attack 271

    Assessment of a stroke 271

    Treatment 272

    Conclusion 274

    References 274

    Further reading/resources 275

    Multiple-choice questions 276

    Chapter 16: Medications used in mental health 278

    Liam Rooney

    Aim 278

    Introduction 278

    Neurotransmitters 279

    Antidepressants 280

    Selective serotonin reuptake inhibitors 281

    Monoamine oxidase inhibitors 282

    Serotonin and noradrenaline reuptake inhibitors 283

    Serotonin syndrome 283

    Other atypical antidepressants 284

    Anxiolytics 285

    Pregabalin 285

    Benzodiazepines 285

    Buspirone 286

    Beta-blockers 286

    Hypnotics 286

    Benzodiazepines 286

    Z-drugs 287

    Mood-stabilising medications 287

    Lithium 287

    Valproate 287

    Antipsychotics 288

    Antipsychotic-related side-effects 288

    Other side-effects 289

    Dementia 291

    Acetylcholinesterase inhibitors 291

    Memantine 292

    Attention deficit-hyperactivity disorder 292

    Stimulants 292

    Non-stimulants 292

    Conclusion 293

    Find out more about these conditions 293

    Glossary 293

    References 294

    Further reading 296

    Resources 296

    Multiple-choice questions 296

    Chapter 17: Immunisations 299

    Michael Fanner

    Aim 299

    Introduction 299

    Understanding the fundamental epidemiological concepts and theories in preventing infectious diseases 300

    Essential ways of examining infectious diseases 301

    Becoming familiar with vaccine design to underpin clinical practice knowledge 302

    Vaccine design 302

    Appreciating public concerns in the acceptability and uptake of immunisations 303

    Vaccine acceptability 307

    Recognising the role of the paramedic in health promotion and immunisation administration 308

    Immunisations as prescription-only medicines 308

    Embedding immunisation history taking in clinical assessment 309

    Conclusion 315

    References 316

    Further reading 317

    Multiple-choice questions 317

    Normal Values 319

    Answers 323

    Index 325